NSA 11/19/19 HBS VAC Sickle Cell Management - Part 1
Physicians will expand the knowledge of basic aspects of care for patients with Sickle Cell Disease (SCD). Specifically, highlighted are several clinical actions to enhance preventive care, manage some of the most common acute and chronic complications of SCD, and initiate and monitor the two Sickle Cell Disease-specific disease- modifying therapies, hydroxyurea and chronic blood transfusion therapy, helping to reduce unnecessary blood transfusions and better patient outcomes.
1. Recognize when blood transfusion or exchange transfusion is indicated.
2. Assess the management of acute chest syndrome, sickle cell pain crisis, and indications for acute hospitalization.
3. Identify the indications for pharmaceuticals used in management of sickle cell disease.
Andrew Liu, MD/ Hospital Medicine, Kaiser Permanente Vacaville.
Daniel Lee, MD, Hematology/Oncology Department, Kaiser Permanente Napa Solano Area
Kaiser Permanente Napa/Solano has determined that today's speaker and planner(s) do not have affiliations with any corporate organizations that may constitute a conflict of interest with this presentation. Kaiser Permanente Napa/Solano takes responsibility for the content, quality and scientific integrity of this CME activity. Kaiser Permanente does not endorse any brand-name products.
Kaiser Napa Solano Area is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians. The Kaiser Napa Solano Area designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit(s)™